|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.82 CAD | -0.08% |
|
+0.05% | +45.40% |
| Jun. 05 | Boralex Secures Final Court Approval for $9-Billion Sale to Brookfield and CDPQ | MT |
| Jun. 04 | Boralex Inc. - Shareholder/Analyst Call |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.07 | 2 | 2.34 | 2.04 | 1.5 | |||||
Return on Total Capital | 2.29 | 2.28 | 2.72 | 2.41 | 1.76 | |||||
Return On Equity % | 2.36 | 0.49 | 5.68 | 3.66 | 1.64 | |||||
Return on Common Equity | 1.71 | 2.24 | 4.71 | 2.23 | 0.45 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 77.86 | 69.14 | 62.82 | 76.79 | 75.97 | |||||
SG&A Margin | 5.35 | 6.58 | 6.26 | 8.79 | 8.36 | |||||
EBITDA Margin % | 66.28 | 55.86 | 50.49 | 58.97 | 56.18 | |||||
EBITA Margin % | 39.8 | 35.41 | 31.7 | 37.05 | 30.62 | |||||
EBIT Margin % | 26.48 | 23.56 | 24.07 | 27.08 | 21.55 | |||||
Income From Continuing Operations Margin % | 3.76 | 0.96 | 11.25 | 8.68 | 3.89 | |||||
Net Income Margin % | 2.46 | 3.59 | 7.63 | 4.22 | 0.82 | |||||
Net Avail. For Common Margin % | 2.46 | 3.59 | 7.63 | 4.22 | 0.82 | |||||
Normalized Net Income Margin | 3.4 | 10.63 | 7.2 | 6.61 | 0.91 | |||||
Levered Free Cash Flow Margin | 21.96 | 30.25 | 11.48 | 13.04 | -80.85 | |||||
Unlevered Free Cash Flow Margin | 32.33 | 38.29 | 18.57 | 21.5 | -70.04 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.12 | 0.14 | 0.16 | 0.12 | 0.11 | |||||
Fixed Assets Turnover | 0.2 | 0.23 | 0.28 | 0.21 | 0.19 | |||||
Receivables Turnover (Average Receivables) | 4.4 | 4.28 | 4.23 | 3.27 | 3.13 | |||||
Inventory Turnover (Average Inventory) | - | - | - | - | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.16 | 0.78 | 1.08 | 0.96 | 1.29 | |||||
Quick Ratio | 1.02 | 0.72 | 1 | 0.89 | 1.05 | |||||
Operating Cash Flow to Current Liabilities | 0.87 | 0.62 | 0.69 | 0.22 | 0.71 | |||||
Days Sales Outstanding (Average Receivables) | 82.95 | 85.23 | 86.29 | 111.99 | 116.7 | |||||
Days Outstanding Inventory (Average Inventory) | - | - | - | - | - | |||||
Average Days Payable Outstanding | 331.6 | 72.15 | 45.62 | 26.8 | 302.38 | |||||
Cash Conversion Cycle (Average Days) | - | - | - | - | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 325.35 | 178.83 | 179.25 | 213.43 | 234.51 | |||||
Total Debt / Total Capital | 76.49 | 64.14 | 64.19 | 68.1 | 70.11 | |||||
LT Debt/Equity | 305.86 | 157.4 | 164.58 | 195.36 | 221.7 | |||||
Long-Term Debt / Total Capital | 71.91 | 56.45 | 58.93 | 62.33 | 66.28 | |||||
Total Liabilities / Total Assets | 78.94 | 69.02 | 69.21 | 73.37 | 73.97 | |||||
EBIT / Interest Expense | 1.34 | 1.52 | 1.82 | 1.74 | 1.1 | |||||
EBITDA / Interest Expense | 3.5 | 3.78 | 3.99 | 3.97 | 3.04 | |||||
(EBITDA - Capex) / Interest Expense | 2.28 | 1.89 | 2.07 | 0.98 | -0.64 | |||||
Total Debt / EBITDA | 8.21 | 7.36 | 6.73 | 8.19 | 9.26 | |||||
Net Debt / EBITDA | 7.68 | 6.63 | 5.84 | 7.06 | 8.68 | |||||
Total Debt / (EBITDA - Capex) | 12.59 | 14.73 | 13 | 33.25 | -43.64 | |||||
Net Debt / (EBITDA - Capex) | 11.77 | 13.26 | 11.29 | 28.69 | -40.9 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 9.16 | 20.98 | 22.25 | -16.54 | -0.47 | |||||
Gross Profit, 1 Yr. Growth % | 11.62 | 7.43 | 11.07 | 0.15 | -1.53 | |||||
EBITDA, 1 Yr. Growth % | 15.95 | 1.3 | 10.49 | -2.52 | -5.17 | |||||
EBITA, 1 Yr. Growth % | 19.05 | 6.47 | 9.46 | -2.47 | -17.72 | |||||
EBIT, 1 Yr. Growth % | 3.39 | 5.91 | 24.87 | -6.1 | -20.78 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -57.38 | -69.23 | 1.34K | -35.65 | -55.41 | |||||
Net Income, 1 Yr. Growth % | -69.09 | 76.47 | 160 | -53.85 | -80.56 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -70.91 | 82.52 | 159.9 | -53.89 | -82.86 | |||||
Normalized Net Income, 1 Yr. Growth % | -39.74 | 278.19 | -17.16 | -23.43 | -86.1 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.01 | 1.13 | 1.36 | 19.36 | 4.9 | |||||
Inventory, 1 Yr. Growth % | - | - | - | - | - | |||||
Accounts Receivable, 1 Yr. Growth % | -5.73 | 58.11 | 0.85 | 11.86 | -7.2 | |||||
Total Assets, 1 Yr. Growth % | 8.22 | 13.7 | 0.54 | 15.67 | 0.58 | |||||
Tangible Book Value, 1 Yr. Growth % | 40 | -206.87 | 5.14 | -1.96 | -13.97 | |||||
Cash From Operations, 1 Yr. Growth % | -4.7 | 48.7 | -3.31 | -56.65 | 68.37 | |||||
Capital Expenditures, 1 Yr. Growth % | 15.17 | 47.31 | 5.69 | 53.08 | 53.52 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -17.25 | 67.88 | -53.58 | -5.22 | -1.24K | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -8.69 | 44.04 | -40.73 | -3.36 | -549.2 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 0 | 0 | 0 | |||||
Common Equity, 1 Yr. Growth % | 1.21 | 67.93 | -3.09 | -1.72 | -3.69 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 9.72 | 14.92 | 21.61 | 1.01 | -8.86 | |||||
Gross Profit, 2 Yr. CAGR % | 9.71 | 9.51 | 9.24 | 6.45 | -0.69 | |||||
EBITDA, 2 Yr. CAGR % | 10.96 | 8.73 | 5.8 | 3.78 | -3.85 | |||||
EBITA, 2 Yr. CAGR % | 18.75 | 13.2 | 7.96 | 3.32 | -10.42 | |||||
EBIT, 2 Yr. CAGR % | 13.12 | 5.5 | 15 | 8.29 | -13.75 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -22.24 | -63.79 | 110.31 | 204.14 | -46.43 | |||||
Net Income, 2 Yr. CAGR % | -33.98 | -26.15 | 114.2 | 9.54 | -70.04 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -39.03 | -27.13 | 117.8 | 9.47 | -71.88 | |||||
Normalized Net Income, 2 Yr. CAGR % | 19.34 | 50.96 | 77 | -20.36 | -67.56 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 10.52 | 3.54 | 1.24 | 9.99 | 11.9 | |||||
Accounts Receivable, 2 Yr. CAGR % | -1.65 | 22.08 | 26.28 | 6.22 | 1.89 | |||||
Total Assets, 2 Yr. CAGR % | 12.34 | 10.93 | 6.92 | 7.84 | 7.86 | |||||
Common Equity, 2 Yr. CAGR % | 7.89 | 30.37 | 27.57 | -2.41 | -2.71 | |||||
Tangible Book Value, 2 Yr. CAGR % | 260.56 | 22.32 | 6 | 1.53 | -8.16 | |||||
Cash From Operations, 2 Yr. CAGR % | 8.33 | 19.04 | 19.9 | -35.26 | -14.57 | |||||
Capital Expenditures, 2 Yr. CAGR % | 2.48 | 30.25 | 24.78 | 27.2 | 53.3 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 18.2 | 17.43 | -11.72 | -33.67 | 141.82 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 10.67 | 14.4 | -7.6 | -24.31 | 77.02 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 0 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 12.99 | 13.35 | 17.31 | 7.27 | 0.52 | |||||
Gross Profit, 3 Yr. CAGR % | 15.85 | 8.94 | 10.03 | 6.78 | 3.72 | |||||
EBITDA, 3 Yr. CAGR % | 16.45 | 7.88 | 9.32 | 2.95 | 0.71 | |||||
EBITA, 3 Yr. CAGR % | 30.06 | 14.93 | 11.94 | 4.36 | -4.23 | |||||
EBIT, 3 Yr. CAGR % | 31.76 | 11.27 | 11.6 | 7.49 | -2.43 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -11.88 | -42.91 | 23.53 | 41.72 | 60.38 | |||||
Net Income, 3 Yr. CAGR % | -17.25 | -8.37 | 12.35 | 28.42 | -38.44 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -24.69 | -12.13 | 11.33 | 29.81 | -40.99 | |||||
Normalized Net Income, 3 Yr. CAGR % | 25.11 | 75.29 | 23.59 | 33.87 | -55.66 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.59 | 7.3 | 2.81 | 6.95 | 8.27 | |||||
Inventory, 3 Yr. CAGR % | - | - | - | - | - | |||||
Accounts Receivable, 3 Yr. CAGR % | 18.47 | 15.21 | 14.55 | 21.28 | 1.54 | |||||
Total Assets, 3 Yr. CAGR % | 6.48 | 12.79 | 7.35 | 9.76 | 5.36 | |||||
Common Equity, 3 Yr. CAGR % | 4.55 | 25.03 | 18.1 | 16.95 | -2.84 | |||||
Tangible Book Value, 3 Yr. CAGR % | 45.98 | 140.4 | 16.3 | 3.28 | -3.92 | |||||
Cash From Operations, 3 Yr. CAGR % | 19.53 | 20.39 | 11.07 | -14.58 | -10.97 | |||||
Capital Expenditures, 3 Yr. CAGR % | -16.02 | 15.66 | 21.49 | 33.57 | 35.43 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -5.97 | 32.53 | -13.82 | -9.61 | 39.49 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 26.25 | 20.63 | -8.12 | -6.21 | 22.93 | |||||
Dividend Per Share, 3 Yr. CAGR % | 1.56 | 0 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 18 | 14.81 | 16.37 | 8.24 | 6.05 | |||||
Gross Profit, 5 Yr. CAGR % | 20.13 | 13.2 | 13.16 | 7.94 | 6 | |||||
EBITDA, 5 Yr. CAGR % | 20.27 | 11.58 | 12.21 | 6.22 | 3.84 | |||||
EBITA, 5 Yr. CAGR % | 25.59 | 17.71 | 20.98 | 10.14 | 2.39 | |||||
EBIT, 5 Yr. CAGR % | 22.63 | 15.22 | 25.19 | 10.07 | 0.67 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 67.03 | -4.36 | 24.79 | 11.47 | -11.56 | |||||
Net Income, 5 Yr. CAGR % | 53.42 | 6.4 | 21.06 | -1.59 | -33.79 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 39.14 | 0.14 | 15.17 | -4.05 | -35.8 | |||||
Normalized Net Income, 5 Yr. CAGR % | 22.92 | 49.25 | 43.74 | 27.86 | -27.62 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 16.85 | 6.99 | 5 | 8.37 | 6.35 | |||||
Inventory, 5 Yr. CAGR % | - | - | - | - | - | |||||
Accounts Receivable, 5 Yr. CAGR % | 29.27 | 20.53 | 21.54 | 11.53 | 9.31 | |||||
Total Assets, 5 Yr. CAGR % | 16.31 | 10.74 | 6.65 | 10.78 | 7.55 | |||||
Common Equity, 5 Yr. CAGR % | 15.08 | 19.67 | 13.21 | 13.23 | 9.29 | |||||
Tangible Book Value, 5 Yr. CAGR % | 46.47 | 20.68 | 28.44 | 70.29 | 5.82 | |||||
Cash From Operations, 5 Yr. CAGR % | 18.44 | 28.75 | 19.68 | -6.07 | 0 | |||||
Capital Expenditures, 5 Yr. CAGR % | -5.62 | 1.27 | -1.61 | 20.14 | 33.33 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 7.62 | 7.89 | -8.45 | 0.48 | 30.21 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 27.71 | 23.29 | 11.32 | 0.11 | 19.44 | |||||
Dividend Per Share, 5 Yr. CAGR % | 3.71 | 1.92 | 0.93 | 0 | 0 |
- Stock Market
- Stocks
- BLX Stock
- Financials Boralex Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















